TAmiRNA to Exhibit at the Precision Medicine EV Forum 2025 in Cambridge
Vienna, October 2025 – TAmiRNA GmbH, a leading provider of extracellular vesicle (EV) transcriptomic services, is pleased to announce its participation as an exhibitor at the Precision Medicine EV Forum 2025, taking place in Cambridge, UK, from October 27th to 28th.
The forum, a key event focused on the translational aspects of EV research, provides a platform for TAmiRNA to showcase its cutting-edge solutions for biomarker discovery and therapeutic development.
Meet Our Experts
Our CEO/CSO, Matthias Hackl, PhD, and Scientific Consultant, Magdalena Mecking, MSc, will be on-site to meet with researchers and industry leaders. They will be available to discuss how TAmiRNA’s proprietary workflows and deep bioinformatics expertise can deliver the robust EV RNA characterization data necessary to advance complex research projects.
New Scientific Insights: The isomiR Landscape
TAmiRNA is proud to contribute to the scientific program by presenting a poster detailing our latest findings:
Poster Title: “Preserving the Message: isomiR Landscapes in Cells, EVs, and Protein Complexes”
This research provides crucial new insights into the biology of extracellular vesicles, specifically demonstrating how they preserve the diversity of intracellular microRNA isoforms (isomiRs). Understanding these unique isomiR signatures offers new opportunities in developing next-generation, high-resolution biomarkers.
Connect with TAmiRNA
We invite all attendees to visit our booth to discuss your current projects, learn more about our validated workflows, and explore opportunities for partnership.
We look forward to a successful forum and to connecting with the EV community in Cambridge.
Leave A Comment
You must be logged in to post a comment.